期刊
SMALL
卷 17, 期 47, 页码 -出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.202103712
关键词
artificial individualization receptors; cancer theranostics; reversible activation; structure-stable nanotherapeutics; structure-transformable nanogatekeepers
类别
资金
- Anhui University of Chinese Medicine Foundation [2020py04, 2021py05]
- Key Project of Anhui Province Department of Education [KJ2020A0429]
- National Nature Science Foundation of China [82003675, 81873019]
Nanoparticulate drug delivery systems face challenges in reaching tumor sites and minimizing off-target side effects. Nanogatekeepers designed with structure-transformable and stable strategies can undergo transformation in tumor microenvironments. Intelligent structure-stable nanogatekeepers with reversible activation and individualized receptors aim to improve drug delivery systems.
Nanoparticulate drug delivery systems (nano-DDSs) are required to reliably arrive and persistently reside at the tumor site with minimal off-target side effects for clinical theranostics. However, due to the complicated environment and high interstitial pressure in tumor tissue, they can return to the bloodstream and cause secondary side effects in normal organs. Recently, a number of nanogatekeepers have been engineered via structure-transformable/stable strategies to overcome this undesirable dilemma. The emerging structure-transformable nanogatekeepers for tumor imaging and therapy are first overviewed here, particularly for nanogatekeepers undergoing structural transformation in tumor microenvironments, cell membranes, and organelles. Thereafter, intelligent structure-stable nanogatekeepers through reversible activation and artificial individualization receptors are overviewed. Finally, the ongoing challenges and prospects of nanogatekeepers for clinical translation are briefly discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据